Scientific Research Fund of Binzhou Medical University (BY2021KYQD032), National Natural Science Foundation of China (grant number 82200981), Special Funds of Taishan Scholars Project of Shandong Province (grant number tsqn202312384), and the Natural Science Foundation of Shandong Province (grant number ZR2022QH358)
Global Semaglutide Market Trends and Insights Drivers Impact Analysis * Rising Prevalence of Obesity & Type-2 Diabetes Global obesity surpassed 1 billion adults in 2024, while 537 million people lived with diabetes, creating fundamental demand for therapies that address both conditions
Patients who want or need blood work can reach out to the care team to discuss options, but there is no required lab check before the first prescription or at any follow-up point during ongoing care
GLP-1 medications offer several advantages over insulin for many patients with Type 2 diabetes
For efficient uptake of the construct into cells, injection needs to be followed by electroporation